arrow_back Trending Legislation
Share share

Safer Medications: Better Dosing Through Genetics

This act aims to enhance medication safety by better tailoring drugs and their dosages to individual patient genetic profiles. This will help citizens avoid adverse drug reactions, increasing treatment effectiveness and reducing complication risks. Changes include educating healthcare professionals and improving electronic health record systems.
Key points
Better Drug Matching: Doctors will have genetic information to select safer drugs and dosages for each patient.
Fewer Side Effects: The risk of adverse drug reactions will decrease, improving treatment safety and comfort.
Improved Medical Records: Electronic systems will better support doctors in medication decisions, considering patient genetics.
Healthcare Professional Education: Medical staff will be trained on using genetic tests in treatment.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Right Drug Dose Now Act of 2024
Print number: HR 7848
Sponsor: Rep. Swalwell, Eric [D-CA-14]
Process start date: 2024-03-29
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Safer Medications: Better Dosing Through Genetics

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 7848.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-03-29.

What are the main provisions?

Key points include:

  • Better Drug Matching: Doctors will have genetic information to select safer drugs and dosages for each patient.
  • Fewer Side Effects: The risk of adverse drug reactions will decrease, improving treatment safety and comfort.
  • Improved Medical Records: Electronic systems will better support doctors in medication decisions, considering patient genetics.
  • Healthcare Professional Education: Medical staff will be trained on using genetic tests in treatment.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Swalwell, Eric [D-CA-14].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 7848

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health